Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 36
Healthy volunteers: yes

Brief summary:
The objective of this study was to compare the rate and extent of absorption of Teva Pharmaceuticals USA valacyclovir and GlaxoSmithKline, USA (Valtrex) valacyclovir, administered as 1 x 1000 mg tablet under fed conditions.

Detailed description:

Arms:
arm 1: Test 1000 mg Tablet arm 2: Reference Listed Valacyclovir 1000 mg Tablet

Interventions: intervention 1: Valacyclovir intervention 2: Valacyclovir
Intervention descriptions: intervention 1: Test 1000 mg Tablet intervention 2: Reference Listed Valacyclovir 1000 mg Tablet

Protocol document: